COVID-19: XBB.1.5 Cases Evade Therapeutics; Racial and Ethnic Disparities in Pediatric Vaccination Status
Jan. 10, 2023 ||FDA and CDC say Evusheld is unlikely to neutralize the XBB.1.5 subvariant, and a CDC report indicates COVID-19 vaccination in children and adolescents is highest among Asian and Hispanic youth.
view more »